The DEA is launching its second attempt to classify five obscure psychedelic compounds as Schedule I illegal drugs, directly clashing with the FDA’s ongoing efforts to legitimize them. While the DEA cites decades-old, non-lethal poison control data to justify a total ban, the FDA recently granted "breakthrough therapy" status to one of these exact substances as a promising … [Read more...] about The DEA is Trying to Arrest Your Future Antidepressants
DEA
Be Careful What You Weed For: The DEA Trades Its Handcuffs for Clipboards
The cannabis industry spent over a decade knocking on the front door of Capitol Hill, begging Uncle Sam to treat it like a legitimate trade instead of an illicit racket. Now, courtesy of a shift toward Schedule III under the Trump administration, the feds have finally answered the bell—except the welcoming committee isn't a cheerful ribbon-cutter from the Department of … [Read more...] about Be Careful What You Weed For: The DEA Trades Its Handcuffs for Clipboards
2,500 Pages of Bureaucratic Buzzkill: The DEA Drops Its Mega-Transcript
The federal government has finally handed the public some truly hefty bedtime reading, releasing the complete official transcript from eleven exhausting days of hearings on moving marijuana from Schedule I to Schedule III. Spanning a breezy 2,533 pages, the newly published document chronicles every legal skirmish, scientific argument, and procedural hiccup after DEA Chief … [Read more...] about 2,500 Pages of Bureaucratic Buzzkill: The DEA Drops Its Mega-Transcript
Bye Bye HHC
The Drug Enforcement Administration is urging a federal appeals court to throw out a lawsuit brought by the hemp industry over hexahydrocannabinol, or HHC, defending its longstanding position that the psychoactive cannabinoid remains an illegal Schedule I controlled substance. In a brief filed with the U.S. Court of Appeals for the Fourth Circuit, federal regulators argued that … [Read more...] about Bye Bye HHC
Behind Closed Doors: What the DEA Doesn’t Want You to See at the Historic Cannabis Hearing
Right now, the most consequential federal cannabis hearing in over half a century is unfolding in a Virginia courtroom. The catch? You aren't allowed to watch it. When the DEA convened this historic showdown on June 29 to debate moving marijuana out of Schedule I, the agency instituted a virtual media blackout: no cameras, no livestreams, and just a handful of public seats. … [Read more...] about Behind Closed Doors: What the DEA Doesn’t Want You to See at the Historic Cannabis Hearing
The Waiting Game: Is Federal Rescheduling the Fix Connecticut’s Cannabis Market Needs?
For Connecticut’s cannabis entrepreneurs, the buzz surrounding the potential federal move to reclassify marijuana from Schedule I to Schedule III is palpable. It is being hailed as a historic milestone, but if you talk to those on the ground—the business owners, policy experts, and dispensary managers—the mood is less of a victory lap and more of a cautious "wait and see." … [Read more...] about The Waiting Game: Is Federal Rescheduling the Fix Connecticut’s Cannabis Market Needs?
DEA Doubles Down: Synthetic Cannabinoid HHC is Dead on Arrival
The federal government is slamming the door on the Wild West of synthetic legal highs. In a series of aggressive new legal filings, the Drug Enforcement Administration (DEA) has defended its stance that hexahydrocannabinol (HHC)—a semi-synthetic cannabinoid dominating smoke shops across America—is a strictly banned, Schedule I controlled substance. The defense comes as the … [Read more...] about DEA Doubles Down: Synthetic Cannabinoid HHC is Dead on Arrival
Rescheduling Hearing Drama: NORML Wants In
As the federal government prepares to revisit marijuana's classification under the Controlled Substances Act, one of the country's oldest cannabis advocacy organizations says it has been unfairly locked out of the conversation.The National Organization for the Reform of Marijuana Laws (NORML) has formally asked the Drug Enforcement Administration (DEA) to reconsider its … [Read more...] about Rescheduling Hearing Drama: NORML Wants In
DEA Limits Marijuana Hearing Participation — Reform Groups Cry Foul
The upcoming federal marijuana rescheduling hearing is already drawing controversy before it even begins. According to reports, the Drug Enforcement Administration has restricted participation in its June 29 hearing on moving cannabis from Schedule I to Schedule III to a small group of selected stakeholders — and critics say the lineup is heavily tilted toward opponents of … [Read more...] about DEA Limits Marijuana Hearing Participation — Reform Groups Cry Foul
DEA Begins On-Site Inspections at Marijuana Businesses Seeking Federal Protections Under Rescheduling Plan
The Drug Enforcement Administration (DEA) has started conducting on-site inspections at state-licensed marijuana businesses that applied for federal protections under the Trump administration’s ongoing cannabis rescheduling framework. The inspections mark one of the first visible enforcement steps tied to the federal government’s partial shift in marijuana policy, which … [Read more...] about DEA Begins On-Site Inspections at Marijuana Businesses Seeking Federal Protections Under Rescheduling Plan
